3442
A. R. Karimi et al. / Tetrahedron Letters 53 (2012) 3440–3443
12. Hayashi, Y.; Yamaguchi, J.; Hibino, K.; Shoji, M. Angew. Chem., Int. Ed. 2004, 43,
120
100
80
60
40
20
0
1112.
13. Brochu, M. P.; Brown, S. P.; MacMillan, D. W. C. J. Am. Chem. Soc. 2004, 126,
4108.
14. Samai, S.; Nandi, G. Ch.; Singh, P.; Singh, M. S. Tetrahedron 2009, 65, 10155.
15. Pandey, J.; Anand, N.; Tripathi, R. P. Tetrahedron 2009, 65, 9350.
16. Misra, M.; Pandey, S. K.; Pandey, V. P.; Pandey, J.; Tripathi, R.; Tripathi, R. P.
Bioorg. Med. Chem. Lett. 2009, 17, 625.
17. Abdolmohammadi, Sh.; Balalaie, S. Tetrahedron Lett. 2007, 48, 3299.
18. Mukhopadhyay, Ch.; Tapaswi, P. K.; Butcher, R. J. Tetrahedron Lett. 2010, 51,
1797.
*
19. Liu, X. Z.; Xu, X. M.; Hu, R.; Du, C.; Zhang, S. X.; McDonald, J. W.; Dong, H. X.;
Wu, Y. J.; Fan, G. S.; Jacquin, M. F.; Hsu, C. Y.; Choi, D. W. J. Neurosci. 1997, 17,
5395.
0 h
6 h (control)
6 h (4f)
20. Prediger, R. D. J. Alzheimers Dis. 2010, 20, S205.
21. Martin, L. J.; Price, A. C.; Kaiser, A.; Shaikh, A. Y.; Liu, Z. Int. J. Mol. Med. 2000, 5,
3.
22. Pizzi, M.; Benarese, M.; Boroni, F.; Goffi, F.; Valerio, A.; Spano, P. F.
Neuropharmacology 2000, 39, 903.
Figure 2. Percentage of motor neuron viability at 0 h and 6 h in the absence
(control) or presence of 4f (300
M). Mean SD, n = 12, ⁄P <0.01.
l
23. Ranganathan, S.; Bowser, R. Open Pathol. J. 2010, 4, 11.
24. Momeni, H. R.; Azadi, S.; Kanje, M. Funct. Neurol. 2007, 22, 105.
25. Schauwecker, P. E. Exp. Neurol. 2010, 224, 207.
26. Sharifi, A. M.; Eslami, H.; Larijani, B.; Davoodi, J. Neurosci. Lett. 2009, 459, 47.
27. Momeni, H. R.; Kanje, M. Neuroreport 2005, 1065, 16.
28. (a) Markmee, S.; Ruchirawat, S.; Prachyawarakorn, V.; Ingkaninan, K.; Khorana,
N. Bioorg. Med. Chem. Lett. 2006, 16, 2170; (b) Sperlinga, E.; Kosson, P.;
Urbanczyk-Lipkowska, Z.; Ronsisvalle, G.; Carr, D. B.; Lipkowski, A. W. Bioorg.
Med. Chem. Lett. 2005, 15, 2467.
29. Kotake, Y.; Taguchi, R.; Okuda, K.; Sekiya, Y.; Tasaki, Y.; Hirobe, M.; Ohta, S.
Brain Res. 2005, 1033, 143.
30. Pellicciari, R.; Camaioni, E.; Costantino, G.; Marinozzi, M.; Macchiarulo, A.;
Moroni, F.; Natalini, B. Farmaco 2003, 58, 851.
31. Kwon, I. H.; Choi, H. S.; Shin, K. S.; Lee, B. K.; Lee, C. K.; Hwang, B. Y.; Lim, S. C.;
Lee, M. K. Neurosci. Lett. 2010, 486, 29.
32. Azizian, J.; Mohammadi, A. A.; Karimi, A. R.; Mohammadizadeh, M. R. J. Org.
Chem. 2005, 70, 350.
33. Yu, N.; Bourel, L.; Deprez, B.; Gesquiere, J. C. Tetrahedron Lett. 1998, 39, 829.
34. Karimi, A. R.; Pashazadeh, R. Synthesis 2010, 437.
35. Yadav, J. S.; Reddy, B. V. S.; Saritha Raj, K.; Prasad, A. R. Tetrahedron 1805, 2003,
59.
36. Yu, N.; Poulain, R.; Gesquiere, J. C. Synlett 2000, 355.
37. Wang, L.; Liu, J.; Tian, H.; Qian, Ch.; Sun, J. Adv. Synth. Catal. 2005, 347, 689.
38. Vara, Y.; Bello, T.; Aldaba, E.; Arrieta, A.; Pizarro, J. L.; Arriortua, M. I.; Lopez, X.;
Cossio, F. P. Org. Lett. 2008, 10, 4759.
horns after 6 h compared with the control (Fig. 2). Compounds 4a–
e,g,h had no effect on apoptosis inhibition nor on the viability of
the motor neurons (data not shown).
Isoquinoline compounds may exert their neuroprotective ef-
fects through different mechanisms such as poly (ADP-ribose)
polymerase (PARP) inhibition,30 glutamate receptor antagonist,39
and free radical scavenging.40 How 4f prevents apoptosis in the
motor neurons remains to be investigated. One possibility might
be related to the substituent on this component. A methoxy group
on the benzene-fused ring is reported to be crucial for producing
pharmacological effects.41 In this context, isoquinoline compounds
with this substituent have been demonstrated as 2-amino-3-hy-
droxy-5-methylisoxazole-4-propionic acid (AMPA) receptor antag-
onists.39 Over activation of this type of glutamate receptor in the
CNS is documented to induce neural cell death in neurological dis-
orders.42 Therefore, it is reasonable to assume that 4f with its
methoxy group was able to exert its neuroprotective effects by
reducing apoptosis of the motor neurons as an AMPA receptor
antagonist.43
39. Gitto, R.; De Luca, L.; Pagano, B.; Citraro, R.; De Sarro, G.; Costa, L.; Ciranna, L.;
Chimirri, A. Bioorg. Med. Chem. 2008, 16, 2379.
40. Jang, M. H.; Kim, H. Y.; Kang, K. S.; Yokozawa, T.; Park, J. H. Arch. Pharmacol. Res.
2009, 32, 341.
41. Chimirri, A.; De Luca, L.; Ferro, S.; De Sarro, G.; Ciranna, L.; Gitto, R.
Chemmedchem 2009, 4, 917.
42. Alberdi, E.; Sanchez-Gomez, M. V.; Cavaliere, F.; Perez-Samartin, A.; Zugaza, J.
L.; Trullas, R.; Domercq, M.; Matute, C. Cell Calcium 2010, 47, 264.
In conclusion, we have reported a simple and convenient proto-
col for the multicomponent synthesis of cis-isoquinolonic acids
using L-Proline as the organocatalyst. The proline can catalyze effi-
ciently this reaction with high yields and very good diastereoselec-
tivity. The products may show potential in the development of new
chemotherapeutics.
43. General procedure for the preparation of products 4a–h:
homophthalic anhydride (1 mmol), amine (1 mmol), aldehyde
(1 mmol) and -Proline (10 mol %) in CH3CN (15 mL) was stirred at room
A mixture of
1
2
3
L
Acknowledgment
temperature for 2 h (in.Table 2). Upon completion of the reaction as monitored
by TLC [n-hexane/EtOAc (2/1)], the solvent was evaporated under reduced
pressure and hot EtOH (5 mL) was added to the residue which was then
filtered. A few drops of H2O were added which was cooled to 0 °C. The crystals
resulting were separated by filtration and washed with Et2O and H2O.
2-benzyl-3-(3-methoxyphenyl)-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxylic
We gratefully acknowledge financial support from the Research
Council of Arak University.
acid (4f): White powder: IR (KBr) (m
max, cmÀ1): 3400–2700 (COOH), 3026, 2955,
Supplementary data
1712, 1643. 1H NMR (DMSO-d6, 300 MHz) dH: 3.63 (s, 3H, CH3), 3.88 (d, 1H,
J = 14.1 Hz, CH2), 4.12 (d, 1H, J = 4.6 Hz, CH), 5.23 (br s, 2H, Hmethylene and methine),
6.57 (m, 2H, Harom), 6.76 (s, 1H, Harom), 7.26 (m, 7H, Harom), 7.42 (m, 2H, Harom),
7.98 (s, 1H, Harom), 12.99 (br s, 1H, COOH). Biology: Animals and the culture of
spinal cord slices: Adult female Balb/c mice (23–25 g) were purchased from the
Pasteur Institute of Iran, Tehran. The animals were housed in plastic cages at
20 °C, over 12 h light/dark cycles, and fed with standard commercial laboratory
chew and water. The experiments were approved by the local ethical
committee at Arak University. The animals were deeply anesthetized via an
intraperitoneal injection of sodium pentobarbital (60 mg/kg) and subsequently
killed by heart puncture. The spinal cord was dissected and placed in ice-cold
phosphate-buffered saline (PBS, pH 7.4). The thoracic region of the spinal
Supplementary data associated with this article can be found, in
References and notes
1. Hulme, C.; Gore, V. Curr. Med. Chem. 2003, 10, 51.
2. Dalko, P. I.; Moisan, L. Angew. Chem., Int. Ed. 2004, 43, 5138.
3. Zotova, N.; Broadbelt, L. J.; Armstrong, A.; Blackmond, D. G. Bioorg. Med. Chem.
Lett. 2009, 19, 3934.
4. Kumar, A.; Kumar, M.; Gupta, M. K. Tetrahedron Lett. 2009, 50, 7024.
5. Mangion, I. K.; MacMillan, D. W. C. J. Am. Chem. Soc. 2005, 127, 3696.
6. Bøgevig, A.; Juhl, K.; Kumaragurubaran, N.; Zhuang, W.; Jørgensen, K. N. Angew.
Chem., Int. Ed. 2002, 41, 1790.
7. Sabitha, G.; Fatima, N.; Reddy, E. V.; Yadav, J. S. Adv. Synth. Catal. 2005, 347,
1353.
8. Chandrasekhar, S.; Reddy, N. R.; Sultana, S. S.; Narsihmulu, C.; Reddy, K. V.
Tetrahedron 2006, 62, 338.
9. Jarvo, E. R.; Miller, S. J. Tetrahedron 2002, 58, 2481.
10. Imbriglio, J. E.; Vasbinder, M. M.; Miller, S. J. Org. Lett. 2003, 5, 3741.
11. Wang, J.; Li, H.; Mei, Y.; Lou, B.; Xu, D.; Xie, D.; Guo, H.; Wang, W. J. Org. Chem.
2005, 70, 5678.
cord27 was then sliced transversally into 400 lm thick sections using a
McIlwain tissue chopper (Stoelting, USA). The slices were cultured in a medium
(50% minimum essential medium, 25% Hanks balanced salt solution, 25% horse
serum, 25 mM HEPES, 6 g/L glucose and penicillin–streptomycin, pH 7.3–7.4) in
the absence (control) or presence of the isoquinolins 4a–h. The cultured slices
were then incubated at 37 °C in a humidified atmosphere of 5% CO2 in air for
6 h. Fixation and sectioning: Freshly prepared (0 h) and cultured slices were
fixed in Stefanini’s fixative (2% paraformaldehyde, 0.2% picric acid in 0.1 M
phosphate buffer, pH 7.2) for at least 2 h. The fixed slices were washed in PBS
(3 Â 5 min) and incubated overnight in 20% sucrose in PBS at 4 °C. The slices
were cut into 10 lm thick sections in a cryostat. The sections were collected
and mounted on Poly-l-lysine coated glass slides. Assessment of apoptosis: To